Innovation Ventures Search Results
Narrow Your Results
Filter
Technology PatentStatus
- All (4)
- Issued Patent (1)
- National Phase Entry (2)
- PCT Filing (0)
- Provisional Filing (1)
- US Non-Provisional Filing (0)
Technology Categories
- All (4)
- Diagnostics (1)
- Educational Tools and Consumer Products (0)
- Medical Devices (0)
- Other (0)
- Research Tools (1)
- Software (0)
- Therapeutics (3)
Technology Stage Of Development
- All Results (3)
- Cell and Gene Therapy (1)
- Organoids (0)
- Other Biologics and Macromolecules (0)
- Small Molecule (0)
- Vaccines (2)
Results (4)
Bivalent VLP Ebola Vaccine
Bi-valent spherical virus like particle (VLP) vaccine against Ebola virus.
Multi-Biomarker Panel for Reliable Detection of Septic Shock
A novel means to quickly and accurately predict the risk of death for both children and adults with septic shock.
Norovirus P Particle Vaccine Development Platform
This technology utilizes the Norovirus P particle as a platform for the development of novel vaccines.
Rotavirus Subunit Vaccine Based on Norovirus S Particle Platform
A non-replicating subunit Rotavirus vaccine was developed by using a novel S particle platform and displaying recombinant antigens.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.
